Eversept Partners »

Eli Lilly & Co. shares owned by Eversept Partners

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Eversept Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 13k 777.96

More positions owned by Eversept Partners

Natera (NTRA)
GSK Sponsored Adr (GSK)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Inspire Med Sys (INSP)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Vera Therapeutics Cl A (VERA)
Syndax Pharmaceuticals (SNDX)
United Therapeutics Corporation (UTHR)
PerkinElmer (RVTY)
Bio-techne Corporation (TECH)
Hca Holdings (HCA)
Healthequity (HQY)
Pfizer (PFE)
Celldex Therapeutics Com New (CLDX)
Community Health Systems (CYH)

View all positions for Eversept Partners

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Capital World Investors
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation

View all funds holding Eli Lilly & Co.